Peter Devilee
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 47
- Cancer, Hypoxia, and Metabolism 29
- Genetics top 0.05%
- BRCA gene mutations in cancer 98
- Genomic variations and chromosomal abnormalities 44
- Pathology and Forensic Medicine top 0.1%
- Genetic factors in colorectal cancer 51
- Oncology top 0.2%
- Cancer-related Molecular Pathways 21
- Reproductive Medicine top 0.5%
-
- Adrenal and Paraganglionic Tumors 36
-
- DNA Repair Mechanisms 23
- Co-authors
- Fattaneh A. TavassoliCees J. CornelisseJean‐Pierre BayleyCornelisse CjPeter E.M. TaschnerBert VogelsteinStephen BaylinAntonette C. Preisinger
- Journals
- European Journal of Human Genetics (10 papers)International Journal of Cancer (10 papers)Genes Chromosomes and Cancer (10 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Peter Devilee
217 papers receiving 18.1k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Cancer Research 6.6k
- Genetics 6.5k
- Pathology and Forensic Medicine 3.6k
- Oncology 5.2k
- Reproductive Medicine 1.3k
Countries citing papers authored by Peter Devilee
This map shows the geographic impact of Peter Devilee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Devilee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Devilee more than expected).
Fields of papers citing papers by Peter Devilee
This network shows the impact of papers produced by Peter Devilee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Devilee. The network helps show where Peter Devilee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Devilee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 48 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 17 | |
| 6 | 2021 | 33 | |
| 7 | 2020 | 8 | |
| 8 | 2019 | 3 | |
| 9 | 2019 | 9 | |
| 10 | 2018 | 6 | |
| 11 | 2017 | 17 | |
| 12 | 2013 | 62 | |
| 13 | 2009 | 53 | |
| 14 | SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paragangliomabreakdown → | 2009 | 541 |
| 15 | 2004 | 0 | |
| 16 | Pathology and Genetics of Tumours of the Breast and Female Genital Organsbreakdown → | 2003 | 2215 |
| 17 | 2001 | 62 | |
| 18 | [From gene to disease; from BRCA1 or BRCA2 to breast cancer]. | 2000 | 3 |
| 19 | Prophylactic surgery in BRCA1/2 mutation carriers Predictive factors and follow-up | 1999 | 3 |
| 20 | 1987 | 73 |
About Peter Devilee
Peter Devilee is a scholar working on Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 220 papers that have together received 18.6k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (98 papers), Genetic factors in colorectal cancer (51 papers), Cancer Genomics and Diagnostics (47 papers), Genomic variations and chromosomal abnormalities (44 papers), Adrenal and Paraganglionic Tumors (36 papers), Cancer, Hypoxia, and Metabolism (29 papers), DNA Repair Mechanisms (23 papers) and Cancer-related Molecular Pathways (21 papers). The work is most often cited by research in Cancer Research (6.6k citations), Genetics (6.5k citations) and Pathology and Forensic Medicine (3.6k citations). Peter Devilee has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Fattaneh A. Tavassoli, Cees J. Cornelisse, Jean‐Pierre Bayley, Cornelisse Cj, Peter E.M. Taschner, Bert Vogelstein, Stephen Baylin, Antonette C. Preisinger, Suzanne J. Baker and Janice Nigro. Their work appears in journals such as European Journal of Human Genetics, International Journal of Cancer, Genes Chromosomes and Cancer, Human Mutation and Journal of Medical Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.